Royal Bank of Canada’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,549
| Closed | -$85K | – | 7404 |
|
|
2023
Q1 | $85K | Sell |
3,549
-9,540
| -73% | -$228K | ﹤0.01% | 4931 |
|
|
2022
Q4 | $139K | Buy |
13,089
+5,320
| +68% | +$56.5K | ﹤0.01% | 4742 |
|
|
2022
Q3 | $35K | Buy |
7,769
+4,854
| +167% | +$21.9K | ﹤0.01% | 5435 |
|
|
2022
Q2 | $11K | Sell |
2,915
-4,149
| -59% | -$15.7K | ﹤0.01% | 5901 |
|
|
2022
Q1 | $51K | Sell |
7,064
-4,895
| -41% | -$35.3K | ﹤0.01% | 5611 |
|
|
2021
Q4 | $67K | Buy |
11,959
+5,215
| +77% | +$29.2K | ﹤0.01% | 5674 |
|
|
2021
Q3 | $43K | Buy |
6,744
+210
| +3% | +$1.34K | ﹤0.01% | 5731 |
|
|
2021
Q2 | $55K | Buy |
6,534
+2,026
| +45% | +$17.1K | ﹤0.01% | 5491 |
|
|
2021
Q1 | $48K | Buy |
4,508
+3,619
| +407% | +$38.5K | ﹤0.01% | 5424 |
|
|
2020
Q4 | $15K | Hold |
889
| – | – | ﹤0.01% | 5656 |
|
|
2020
Q3 | $11K | Sell |
889
-71
| -7% | -$879 | ﹤0.01% | 5413 |
|
|
2020
Q2 | $14K | Buy |
960
+460
| +92% | +$6.71K | ﹤0.01% | 5252 |
|
|
2020
Q1 | $5K | Sell |
500
-450
| -47% | -$4.5K | ﹤0.01% | 5563 |
|
|
2019
Q4 | $14K | Sell |
950
-617
| -39% | -$9.09K | ﹤0.01% | 5428 |
|
|
2019
Q3 | $10K | Buy |
+1,567
| New | +$10K | ﹤0.01% | 5167 |
|